For the CEO of Travere, running a rare disease company is personal
PharmaVoice interviews Eric Dube on what it takes to succeed in rare disease research
February 3, 2022 — This week, PharmaVOICE featured a Q&A with our president and CEO Eric Dube on what it takes to succeed in rare disease. The key takeaway? The people within the company, the science, a patient-inspired culture, humility – and a true passion for making a difference.